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Abstract 
Background: As malaria control interventions are scaled-up, rational approaches are needed for monitoring impact 
over time. One proposed approach includes monitoring the prevalence of malaria infection among pregnant women 
and children at the time of routine preventive health facility (HF) visits. This pilot explored the feasibility and utility of 
tracking the prevalence of malaria infection in pregnant women attending their first antenatal care (ANC) visit and 
infants presenting at 9–12 months of age for measles vaccination.
Methods: Pregnant women attending first ANC and infants nine to 12 months old presenting for measles vaccina-
tion at a non-probability sample of 54 HFs in Tanzania’s Lake Zone (Mara, Mwanza and Kagera Regions) were screened 
for malaria infection using a malaria rapid diagnostic test (RDT) from December 2012 to November 2013, regardless 
of symptoms. Participants who tested positive were treated for malaria per national guidelines. Data were collected 
monthly.
Results: Overall 89.9 and 78.1 % of expected monthly reports on malaria infection prevalence were received for 
pregnant women and infants, respectively. Among 51,467 pregnant women and 35,155 infants attending routine 
preventive HF visits, 41.2 and 37.3 % were tested with RDT, respectively. Malaria infection prevalence was 12.8 % [95 % 
confidence interval (CI) 11.3–14.3] among pregnant women and 11.0 % (95 % CI 9.5–12.5) among infants, and varied 
by month. There was good correlation of the prevalence of malaria among pregnant women and infants at the HF 
level (Spearman rho = 0.6; p < 0.001). This approach is estimated to cost $1.28 for every person tested, with the RDT 
accounting for 72 % of the cost.
Conclusions: Malaria infection was common and well correlated among pregnant women and infants attending 
routine health services. Routine screening of these readily accessible populations may offer a practical strategy for 
continuously tracking malaria trends, particularly seasonal variation. Positivity rates among afebrile individuals pre-
senting for routine care offer an advantage as they are unaffected by the prevalence of other causes of febrile illness, 
which could influence positivity rates among febrile patients presenting to outpatient clinics. The data presented here 
suggest that in addition to contributing to clinical management, ongoing screening of pregnant women could be 
used for routine surveillance and detection of hotspots.
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Background
Populations living in sub-Saharan Africa are at greatest 
risk for malaria, where approximately 90 % of deaths are 
estimated to occur, with 70 % of deaths occurring in chil-
dren under 5 years of age [1]. Tanzania has a substantial 
burden of malaria. Among children under-five, recent 
population-based, cross-sectional surveys in 2011/12 
documented an overall national prevalence of malaria 
parasitaemia of 9.2 %, ranging from 0 to 31.8 % across the 
administrative regions [2]. Malaria parasitaemia is simi-
larly prevalent among pregnant women, ranging from 5.5 
to 11.5 % [3, 4].
Over the last decade, Tanzania has gradually scaled-
up malaria control interventions. Insecticide-treated 
nets (ITNs) have been distributed through various 
campaigns, including: the Tanzania National Voucher 
Scheme introduced in 2004 targeting vulnerable 
groups, such as pregnant women and children aged 
under five [5]; the children under five catch-up cam-
paign (U5CC) in 2009 [6]; and, the universal coverage 
campaign (UCC) in 2011 [7]. Artemisinin-based com-
bination therapy (ACT) was introduced as first-line 
treatment in all public facilities in 2006 and malaria 
rapid diagnostic tests (RDTs) were introduced in 2009 
[8]. Indoor residual spraying (IRS) was introduced in 
two districts of Kagera Region in 2007 and expanded 
to 18 districts in the Lake Zone by 2011 [8], where 
malaria prevalence measured by RDT in children aged 
6–59  months was higher (30–41  %) than the rest of 
mainland Tanzania (18  %) in 2007–2008 [9]. Follow-
ing the effective scale-up of multiple malaria control 
interventions, there has been a 45  % reduction in all-
cause under-five mortality from 1999 to 2010 [8]. In 
addition, the Tanzania HIV and Malaria Indicator Sur-
vey (THMIS) 2011–12 found that malaria prevalence 
among children aged 6–59  months had declined to 
9 % nationally, and 8, 19 and 26 % in Kagera, Mwanza 
and Mara Regions, respectively [2]. As malaria control 
interventions are scaled-up, rational approaches are 
needed for monitoring impact over time. The 2008–
13 National Malaria Control Programme (NMCP) 
Monitoring and Evaluation Plan proposed testing of 
pregnant women and children under 5  years of age 
attending reproductive and child health (RCH) clin-
ics as a suitable sentinel population for monitor-
ing longitudinal malaria morbidity trends [10]. This 
study piloted an active screening approach to monitor 
malaria parasitaemia prevalence in two sentinel popu-
lations: (1) pregnant women attending their first ANC 
visit; and, (2) infants eligible for measles vaccination, at 
9–12  months of age attending selected RCH clinics in 
Kagera, Mara and Mwanza Regions, as well as to assess 
the costs of implementing this strategy.
Methods
Study settings
The study was conducted from December 2012 to 
November 2013 in a non-probability sample of 54 health 
facilities where enhanced surveillance for fast tracking 
routine malaria data had been implemented and pur-
posively sampled to provide geographical spread across 
the three regions. The health facilities included 49 (out 
of131 eligible) health centres (37.4 %) and five (out of 42 
eligible) hospitals (11.9  %)) with dedicated RCH clinics 
in Kagera, Mwanza and Mara Regions in the Lake Zone 
of Tanzania (Fig.  1). This pilot was initially proposed in 
the 2008–13 National Malaria Control Program Moni-
toring and Evaluation Plan to inform future policy [10]. 
It was considered advantageous because: (1) there is high 
coverage in antenatal attendances and measles vaccina-
tion (over 90 %); (2) this population represents a homo-
geneous group than can be followed up longitudinally; 
(3) this population is easily reachable; (4) these data can 
provide prospective/longitudinal indications of malaria 
trends; (5) this system does not require extensive finan-
cial resources and is easily implementable under exist-
ing routine health care delivery systems; (6) low-levels 
of training are required; (7) data are easily recorded and 
reported using a modified information system; (9) there 
is the potential to add haemoglobin testing in the same 
facilities to monitor anaemia prevalence; and (10) this 
data collection system will provide a service to the target 
population as all positive cases will be treated immedi-
ately [10]. Subsequently, the 2014–2020 National Malaria 
Strategic Plan (MSP) endorsed the policy of screening 
women at first ANC [11], and in 2015, Tanzania started 
implementation of routine testing of pregnant women 
for malaria at first ANC as part of the antenatal profile. 
In addition, recording and reporting of ANC malaria 
screening results has been integrated into the routine 
health management information system (HMIS).
Sample size estimation
Based on results of a malaria indicator survey done in 
2011/12 [2], malaria prevalence in Kagera, Mwanza and 
Mara Regions was assumed to be approximately 5–15 %. 
A sample size of 300 people per group (women or infants) 
per month was chosen to be sufficient to allow estimation 
of prevalence of malaria of 15 %, with a 95 % confidence 
interval of 11.2–19.6  %. As prevalence decreases, if the 
number of women/infants screened remains constant, 
the confidence intervals around the estimates would 
widen.
Malaria parasite detection
Health facility staff involved in the project were trained 
using the standard National Malaria Control Programme 
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(NMCP) training manuals [12]. In participating RCH 
clinics, pregnant women attending their first antena-
tal clinic (ANC) visit and infants attending for measles 
vaccination were recruited to participate in testing for 
malaria infection with RDT. After obtaining consent, 
the RCH nurses obtained capillary blood via finger or 
heel (for infants) stick for malaria testing using RDT 
(Malaria Ag P.f/Pan, SD Bioline®). In addition to com-
pleting the routine RCH clinic register, test results were 
recorded in a study logbook. No data were collected on 
symptoms. Participants with positive RDT results were 
offered immediate treatment with either artemether-
lumefantrine, for children and pregnant women in their 
second or third trimester, or quinine for pregnant women 
in their first trimester, according to national treatment 
guidelines.
Data on total number of attendees, total number tested 
with RDTs and total number of positive RDTs for both 
pregnant women and infants were aggregated at the facil-
ity level on a monthly basis and submitted to the study 
coordinator for analysis. The district malaria focal per-
son was responsible for collecting and submitting the 
monthly data summary sheets from his/her respective 
district.
Analysis of costs
The direct costs of implementing the RCH pilot were 
estimated. The direct cost elements included: training of 
RCH staff; RCH staff time; consumables (RDT and anti-
malarials); and, travel expenses for monitoring and super-
vision. Training of RCH staff included cost of training 
venue, accommodation for RCH staff, printing of study 
guidelines and reporting forms. Using reported RCH 
attendance, it was estimated that on average two eligible 
infants and three eligible pregnant women attended RCH 
clinic daily. Assuming that each test takes approximately 
20  min to perform and read [13], it was estimated that 
RCH nurses spent 2 h per day on RDT tests and record-
ing of test results. The RDT was considered to be the 
only additional consumable for the testing, and included 
both purchasing costs ($0.55 average price for Pf/PAN, 
SD Bioline in 2013) [14] and distribution costs incurred 
by the Medical Stores Department (MSD) to supply to 
health facilities. The number of RDTs required was based 
on the reported RCH attendance for infants and preg-
nant women for the 12-month study period, assuming 
100  % of attendees were tested. Finally, the travel cost 
for district staff to travel to health facilities for monitor-
ing, supervision and collection of monthly data summa-
ries was estimated. Costs were converted from Tanzania 
shilling (TZs) to US dollars (US$) based on the average 
exchange rate for 2013 of TZs 1600 per US$.
Data analysis
Data were entered and cleaned in a Microsoft Excel 
spreadsheet. Data analysis was conducted using Stata 
Fig. 1 Geographic location of health facilities participating in the study, Mwanza, Mara and Kagera regions
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12.0 (Stata Corporation, College Station, TX, USA). 
Descriptive statistics were used to explore attendance at 
RCH clinics and proportion tested for malaria. Multi-
level mixed-effects logistic regression models were fitted 
to adjust confidence intervals of prevalence estimates for 
clustering of data at health facility levels using the melogit 
routine in Stata [15]. Differences between proportions 
were compared using Chi squared tests. Spearman cor-
relation was use to investigate association between pro-
portion of participants tested and malaria positivity and 
correlation of malaria prevalence estimates between 
pregnant women and infants. To investigate geographic 
variation in attendance, malaria testing and malaria prev-
alence, raster maps were developed using inverse dis-
tance weighting (IDW) based on weighted combination 
of RCH facilities using ArcGIS software (ESRI, Redlands, 
CA, USA). This technique assumes that malaria data 
from a certain health facility are from people residing 
within a certain distance from that facility and therefore 
the variable being mapped (testing rate and malaria prev-
alence) decreased in accuracy with increasing distance 
from its sampled location [16]. Data were examined for 
spatial autocorrelation using Moran’s I test [17, 18].
Results
Reporting by health facilities
A total of 54 health facilities (31.2 % of eligible sites) were 
purposively sampled with geographical spread across 
the three regions. Of the monthly reports expected from 
the 54 health facilities participating in the pilot, 94.0 and 
78.1  % were received for pregnant women and infants, 
respectively (Table  1). The median annual RCH attend-
ance per health facility was 689 (range 107–4911) and 
533 (range 69–1678) for pregnant women and infants, 
respectively. Mara Region had the most complete 
monthly reporting for both pregnant women (95.2 %) and 
infants (92.9  %), while Mwanza Region had the lowest 
reporting rates for both populations (85.6 % for pregnant 
women and 61.7  % for infants). Figure  2a, d show the 
trends of reporting by month.
RCH clinic attendance and malaria testing
A total of 51,467 pregnant women attended their first 
ANC visit and a total of 35,155 infants attended for mea-
sles vaccination at the 54 RCH clinics during this pilot. 
Overall, 21,184 (41.2 %) of pregnant women and 13,130 
(37.3  %) of infants were screened for malaria infection 
(Table  2). Malaria screening rates varied markedly over 
the study period (Fig. 2b, e) and by location (Fig. 3b, e). 
Mwanza Region consistently had the lowest testing rates, 
while in Kagera testing was high in the first 4 months of 
the study, but declined markedly thereafter (Fig. 2b, e).
Malaria prevalence
Among those tested, 12.8  % [95  % confidence interval 
(CI) 11.3–14.3] of pregnant women and 11.0  % (95  % 
CI 9.5–12.5) of infants were positive for malaria infec-
tion (Table  2). Malaria infection prevalence varied over 
the study period (Fig. 2c, f ) with monthly prevalence of 
9.9–14.6 and 5.2–16.7  % among pregnant women and 
infants, respectively, with marked variation by location 
(Fig.  3c, e). Malaria infection prevalence was highest in 
Kagera Region (14.3 and 13.7 % among pregnant women 
and infants, respectively) and lowest in Mara Region 
(11.5 and 7.5  % among pregnant women and infants, 
respectively).
Variation of health facility attendance, malaria testing 
and malaria prevalence
Figure 3 shows the weighted average estimates of health 
facility attendance, malaria test rates and malaria preva-
lence among pregnant women and infants based on 
inverse distance weighing of the health facility observa-
tions. There was wide variation across the study areas in 
both the proportion tested (Fig. 3b, e) and proportion pos-
itive (Fig. 3c, f ), with evidence of high malaria positivity 
Table 1 Summary of reporting by region, December 2012–November 2013
Characteristic Region
Kagera Mara Mwanza Total
Number of health facilities with RCH clinics 48 49 58 155
Number of health facilities participating: n (%) 18 (37.5) 14 (28.6) 22 (37.9) 54 (34.8)
Number of monthly health facility reports expected 216 168 264 648
Pregnant women
 Number of reports received 203 160 226 589
 Proportion of reports received (%) 94.0 95.2 85.6 90.9
Infants aged 9–12 months
 Number of reports received 187 156 163 506
 Proportion of reports received (%) 86.6 92.9 61.7 78.1
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Fig. 2 Distribution of reporting by RCH clinics, testing for malaria and malaria positivity among pregnant women and infants by region, December 
2012–November 2013. Pregnant women: a proportion of RCH clinics reporting; b proportion tested for malaria; c proportion positive for malaria. 
Infants aged 9–12 months: d proportion of RCH clinics reporting; e proportion tested for malaria; f proportion positive for malaria
Table 2 Summary of attendance, testing and malaria positivity by region, December 2012–November 2013
Characteristic Pregnant women Infants aged 9–12 months
Kagera Mara Mwanza Total Kagera Mara Mwanza Total
Number of partici-
pants attending 
clinic
16,844 9177 25,446 51,467 13,798 8050 13,307 35,155
Number tested 8283 6701 6200 21,184 4823 5619 2688 13,130
Proportion of 
participants 
tested (%)
49.2 73.0 24.4 41.2 35.0 69.8 20.2 37.3
Number positive 1158 782 733 2673 668 417 360 1445
Malaria positiv-
ity: % (95 % CI)
14.3 (11.9, 16.8) 11.5 (8.4, 14.7) 11.9 (10.2, 13.6) 12.8 (11.3, 14.3) 13.7 (11.1, 16.3) 7.5 (5.2, 9.8) 13.1 (10.5, 15.8) 11.0 (9.5, 12.5)
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(hotspots) in defined geographic locations. There was 
good correlation between prevalence of malaria among 
pregnant women and infants across the geographic dis-
tribution of reporting sites, especially in the high trans-
mission areas (Fig. 3c, f ). Moran’s I test showed that there 
was no spatial autocorrelation of health facility level 
malaria prevalence among pregnant women (p =  0.155) 
and infants (p = 0.353). The health facility prevalence of 
malaria in pregnant women was correlated with malaria 
prevalence in infants (Spearman rho  =  0.6; p  <  0.001). 
There was no correlation between malaria prevalence and 
proportion of participants tested for malaria among preg-
nant women (Spearman rho = −0.04; p = 0.8) or infants 
(Spearman rho = −0.2; p = 0.3).
Comparison of prevalence with malaria positivity 
in outpatient department
The malaria positivity rate in the outpatient department 
(OPD) of the participating facilities was collected in order 
to compare this to the prevalence among those attend-
ing RCH services. Overall, malaria positivity rates in the 
OPD varied by month and region, ranging from 15.6 to 
53.0 %, with an average of 42.4, 34.8 and 27.4 % in Kagera, 
Mara and Mwanza regions, respectively (Fig. 4). Overall, 
there was a positive correlation between OPD positivity 
rate and positivity for both pregnant women and infants, 
although the correlation was only modest (Spearman’s 
rho = 0.3, p < 0.001for pregnant women and Spearman’s 
rho = 0.4, p < 0.001 for infants) (Fig. 5a, b).
Fig. 3 Geographical variation in RCH clinics attendance, malaria testing and malaria prevalence among pregnant women and infants by district. 
Pregnant women: a number attending RCH clinics; b proportion tested for malaria; c proportion positive for malaria. Infants aged 9–12 months: d 
number attending RCH clinics; e proportion tested for malaria; f proportion positive for malaria
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Costs analysis
The estimated direct costs of undertaking this study, 
based on RCH attendance, are summarized in Table  3. 
The average total cost of testing pregnant women and 
infants per health facility was estimated at US$ 2060.59 
per year. The key cost driver was the cost of pur-
chase and delivery of RDTs to the health facilities that 
accounted for 72 % of the total direct costs. It was esti-
mated that this approach would cost US$1.28 for every 
person tested and the cost per positive test was esti-
mated at US$ 10.70.
Discussion
In an area of Tanzania with high malaria transmission 
where intensive vector control interventions (IRS and 
ITNs) were scaled up and complemented by universal 
access to ACT and RDT, nearly one in eight pregnant 
women and one in ten infants attending RCH clinics 
Fig. 4 Malaria positivity among patients attending outpatient clinic in 54 health facilities participating in sentinel surveillance
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Fig. 5 a Scatter plot of positivity rate at the outpatient department versus the prevalence among enrolled pregnant women. Spearman’s test: 
Kagera (rho 0.4, p < 0.001), Mara (rho = 0.2, p = 0.1), Mwanza (rho = 0.3, p = 0.36), Total (rho = 0.3, p < 0.001). b Scatter plot of positivity rate at 
the outpatient department versus the prevalence among enrolled infants. Spearman’s test: Kagera (rho = 0.4, p = 0.002), Mara (rho 0.5, p = 0.001), 
Mwanza (rho = 0.6, p < 0.001), Total (rho = 0.4, p < 0.001)
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were positive for malaria infection. In general, the trends 
over time and space were similar for the two popula-
tions. Mapping the prevalence by location revealed the 
presence of localized high transmission hotspots for 
both the pregnant women and infants. While malaria 
test positivity rates from the OPD provide a source of 
data, which could be used to identify malaria hotspots, 
these data are influenced by other causes of fever. This 
study piloted a new approach for assessing population-
based prevalence of malaria through targeted screening 
of readily accessible, asymptomatic populations (preg-
nant women and infants) that have high attendance at 
RCH clinics (95.9  % of pregnant women attend at least 
one ANC visit and 74.6  % of infants attend for measles 
vaccination) [19]. Compared to test positivity rate data 
obtained from the OPD, testing of a sentinel population 
(including both symptomatic and asymptomatic indi-
viduals) provides a more stable estimate over time, which 
is unaffected by other circulating illnesses. This data thus 
provides a better measure for monitoring disease trends 
over time. Cross-sectional household surveys are typi-
cally used to provide this data, however, these are costly 
and are performed at widely spaced intervals, which 
does not allow for fine scale tuning of intervention deliv-
ery in the interim. Ongoing, routine screening of readily 
accessible populations may offer a practical strategy for 
continuous monitoring to identify malaria hotspots and 
track the progress of malaria control over time. These 
data complement the data from the OPD, thus combin-
ing these sources could provide a more comprehensive 
understanding of the full epidemiologic picture.
In Tanzania, sentinel population testing of pregnant 
women and children under 5 years of age attending RCH 
clinics was initially proposed in the 2008–13 Malaria 
Monitoring and Evaluation Plan [10]. Following the pilot 
study, the 2014–2020 National Malaria Strategic Plan 
set a strategic intervention to establish countrywide lon-
gitudinal vigilance of malaria parasitaemia in sentinel 
populations: pregnant women and infants at RCH clinics, 
and school-age children [11]. While data obtained from 
these sentinel populations would not obviate the need 
for periodic cross-sectional population-based surveys 
to measure coverage of interventions, the available data 
suggest that the prevalence of anaemia and parasitaemia 
among children presenting to the health facility for rou-
tine immunization is correlated with that among children 
aged 6–30  months detected by household surveys [11]. 
Similarly, data from a recent meta-analysis by van Eijk 
found that the prevalence of malaria among pregnant 
women was strongly correlated with that from household 
surveys of children [20], suggesting that either of these 
populations could be used to provide ongoing informa-
tion about community level prevalence. From a biological 
standpoint, monitoring of infants may be preferable to 
monitoring adult women. The prevalence among infants 
nine to 12 months of age should closely mirror that of all 
children 6–59 months. Since infants have not yet devel-
oped significant immunity, these infections are likely to 
have been recently acquired. Furthermore, infants are 
less likely to have travelled than pregnant women. Thus, 
the prevalence of infection among infants may be more 
likely to represent recent and local transmission dynam-
ics than that in adult women. However, pregnant women 
are more likely to be infected with malaria than non-
pregnant women, and are at greater risk for severe dis-
ease than non-pregnant women [21]. This is particularly 
true for primigravid women, who are at increased risk 
of severe disease, with higher risk of severe anaemia and 
maternal death, higher rates of miscarriage, intrauterine 
demise, premature delivery, low-birth-weight neonates, 
and neonatal death compared to multigravid women 
[22]. Identifying and treating infected pregnant women 
with asymptomatic infections who may otherwise have 
gone untreated may have the added benefit of improving 
birth outcomes [23]. In addition, this may have a benefit 
on transmission, as it has been suggested that pregnant 
women may be a reservoir of transmission [24]. Finally, 
during the first ante-natal care visit, a panel of blood 
Table 3 Direct costs associated with the testing of pregnant women and children in RCH clinics
RCH reproductive and child health; RDT rapid diagnostic test
a Consumables based on reported attendance (assumes 100 % test rate for both pregnant women and infants). Cost of RDT based on average price for 2013 [14]
Cost elements Annual cost (US$) Proportion of total cost (%)
Total for 54 health facilities Average per health facility
Training of RCH staff 7656.25 141.78 7
Personnel: RCH nurses 3240.00 60.00 3
Consumables (RDT)a 80,125.35 1483.80 72
Travel for monitoring and supervision 20,250.00 375.00 18
Total 111,271.60 2060.59 100
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tests is already performed, whereas children present-
ing for measles immunization would not routinely have 
a blood draw. For these reasons, in Tanzania, testing of 
pregnant women was felt to be a better choice for routine 
monitoring than infants, and in 2015, Tanzania started 
implementation of routine testing of pregnant women for 
malaria at first ANC as part of the antenatal profile [25]. 
In addition, recording and reporting of ANC malaria 
screening results has been integrated into the routine 
health management information system (HMIS).
The study estimated the direct costs associated with the 
sentinel population screening pilot. The costs included 
training, staff time required to perform and record the 
test, test kits, and travel expenses for monitoring and 
supervision. These estimates suggest that nearly three-
quarters of direct costs were attributable to purchase and 
delivery costs for RDTs. Nonetheless, reporting of ANC 
malaria testing through routine HMIS, and integration of 
RDT quality assurance monitoring and supervision with 
other routine supervisory activities, that are undertaken 
on a quarterly basis by the district teams, would reduce 
these costs.
This study has a number of potential limitations. The 
low rate of testing in Kagera and Mwanza is a potential 
source of bias and may have underestimated the results. 
The low testing rates were largely attributed to stock-outs 
of RDTs during the study period. Several reasons were 
reported by RCH clinics to explain frequent RDT stock-
outs, including: weak quantification and forecasting by 
health facilities, delayed delivery of RDTs to health facili-
ties by MSD, and stock out at MSD central stores. The 
analysis suggests that malaria prevalence was not corre-
lated with the proportion of participants tested; thus the 
low testing rate is not expected to have biased the results. 
Lack of reporting was partly related to testing activity 
because RCH clinics did not submit any reports where 
testing was absent due to RDT stock-outs. It is likely 
that the low reporting rates, especially among infants 
in Mwanza Region, may have biased the results. In this 
study, participating health facilities were purposively 
selected to provide a geographically spread sample, but 
were not probabilistically selected to support parametric 
statistics and generalizable estimates. While this may be 
a potential source of bias, sampling is not likely to have 
influenced reporting rates and RDT stock-outs. Finally, 
history of recent symptoms for the persons tested was 
not recorded, as it was not part of the routine ANC regis-
ter, making it impossible to know if those who tested pos-
itive had fever or other malaria symptoms in recent days 
(but were asymptomatic at time of the RCH visit). Finally, 
there is evidence to suggest that the HRP-2/pLDH RDTs 
are not sufficiently sensitive to diagnose very low density 
malaria infections in asymptomatic pregnant women 
[26], thus some infections may be missed. Nonetheless, 
if this screening activity also worked to detect very early 
cases of uncomplicated malaria, then this approach could 
benefit low transmission areas where additional efforts 
are needed to reinforce passive case detection.
Conclusions
Routine screening of pregnant women at first ANC and 
infants presenting for measles vaccination may offer a 
practical approach for ongoing monitoring to track the 
progress of malaria control over time. This strategy pro-
vides benefit to the tested individual by identifying and 
treating those with asymptomatic but detectable parasi-
taemia. In addition, the continuous data generated down 
to the sub-district level allows for targeting malaria con-
trol interventions according to the level of transmission. 
Of the two groups, testing of pregnant women is likely 
to be less disruptive to clinic flow, as pregnant women 
already have blood drawn for routine ANC screening, but 
infants may provide a more precise estimate of transmis-
sion variability across sites and over time. Malaria screen-
ing of pregnant women at first ANC should be considered 
as a practical method for continuous routine surveillance 
of malaria prevalence at the sub-district level.
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